About
Vexev is an Australian medical technology company founded in 2018, based in Surry Hills, New South Wales. The company specializes in non-invasive vascular imaging and intelligent patient monitoring, focusing on improving accessibility, affordability, and quality in medical imaging for vascular diseases. The flagship product, VxWave, is an AI-powered autonomous ultrasound platform that automates ultrasound procedures and produces 3D tomographic images comparable to MRI and CT scans. This technology allows non-specialists to perform vascular ultrasound scans, particularly beneficial in dialysis and nephrology clinics. Vexev's mission is to enhance early detection and prevention of vascular diseases while reducing repetitive strain injuries among sonographers through automation. The company collaborates with major healthcare providers, including U.S. Renal Care, to conduct clinical trials aimed at validating the effectiveness of its technology.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2018
-
Annual Revenue $3200000
-
Total Funding $8500000
Location
Surry Hills, New South Wales, Australia, 2010